Scilex Holding Company (SCLXW)

USD 0.21

(-23.88%)

Total Liabilities Summary of Scilex Holding Company

  • Scilex Holding Company's latest annual total liabilities in 2023 was 274.24 Million USD , up 445.35% from previous year.
  • Scilex Holding Company's latest quarterly total liabilities in 2024 Q1 was 281.02 Million USD , up 2.47% from previous quarter.
  • Scilex Holding Company reported annual total liabilities of 50.28 Million USD in 2022, down -83.34% from previous year.
  • Scilex Holding Company reported annual total liabilities of 301.8 Million USD in 2021, up 35.23% from previous year.
  • Scilex Holding Company reported quarterly total liabilities of 319.23 Million USD for 2024 Q2, up 13.6% from previous quarter.
  • Scilex Holding Company reported quarterly total liabilities of 74.97 Million USD for 2023 Q1, up 49.09% from previous quarter.

Annual Total Liabilities Chart of Scilex Holding Company (2023 - 2020)

Historical Annual Total Liabilities of Scilex Holding Company (2023 - 2020)

Year Total Liabilities Total Liabilities Growth
2023 274.24 Million USD 445.35%
2022 50.28 Million USD -83.34%
2021 301.8 Million USD 35.23%
2020 223.18 Million USD 0.0%

Peer Total Liabilities Comparison of Scilex Holding Company

Name Total Liabilities Total Liabilities Difference
Amgen Inc. 90.92 Billion USD 99.698%
AstraZeneca PLC 61.95 Billion USD 99.557%
Biogen Inc. 12.04 Billion USD 97.723%
Gilead Sciences, Inc. 39.37 Billion USD 99.304%
MIRA Pharmaceuticals, Inc. 558.09 Thousand USD -49039.666%
Scilex Holding Company 274.24 Million USD 0.0%